Leonardo Salmena

Room 4211, 1 King's College Circle, M5S 1A8
Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications

When fibrinogen stops clotting and starts plotting: discovery of a new miRNA-GPCR axis in acute myeloid leukemia progression.

When fibrinogen stops clotting and starts plotting: discovery of a new miRNA-GPCR axis in acute myeloid leukemia progression.

Journal: Haematologica
Published: May 27, 2026

A microRNA CRISPR screen reveals microRNA-483-3p as an apoptotic regulator in prostate cancer cells.

A microRNA CRISPR screen reveals microRNA-483-3p as an apoptotic regulator in prostate cancer cells.

Journal: Cell death & disease
Published: April 14, 2025

The lipid phosphatase INPP4B controls pancreatic cancer cell migration and invasion by regulating fibronectin exocytosis.

The lipid phosphatase INPP4B controls pancreatic cancer cell migration and invasion by regulating fibronectin exocytosis.

Journal: The Journal of biological chemistry
Published: February 27, 2025

ITGAV and SMAD4 influence the progression and clinical outcome of pancreatic ductal adenocarcinoma.

ITGAV and SMAD4 influence the progression and clinical outcome of pancreatic ductal adenocarcinoma.

Journal: Molecular oncology
Published: August 02, 2024

The LCLAT1/LYCAT acyltransferase is required for EGF-mediated phosphatidylinositol-3,4,5-trisphosphate generation and Akt signaling.

The LCLAT1/LYCAT acyltransferase is required for EGF-mediated phosphatidylinositol-3,4,5-trisphosphate generation and Akt signaling.

Journal: Molecular biology of the cell
Published: July 18, 2024

Discovery of miRNA-mRNA regulatory networks in glioblastoma reveals novel insights into tumor microenvironment remodeling.

Discovery of miRNA-mRNA regulatory networks in glioblastoma reveals novel insights into tumor microenvironment remodeling.

Journal: Scientific reports
Published: June 17, 2024

Delineating the relationship between circulating osteoprotegerin and bone health in women with a pathogenic variant in BRCA1: A cross-sectional analysis.

Delineating the relationship between circulating osteoprotegerin and bone health in women with a pathogenic variant in BRCA1: A cross-sectional analysis.

Journal: Bone reports
Published: June 04, 2024

'One way, or another, I'm gonna find ya': miR-221-3p finds its targets via small extracellular vesicles.

'One way, or another, I'm gonna find ya': miR-221-3p finds its targets via small extracellular vesicles.

Journal: Haematologica
Published: March 28, 2024

INPP4B promotes PDAC aggressiveness via PIKfyve and TRPML-1-mediated lysosomal exocytosis.

INPP4B promotes PDAC aggressiveness via PIKfyve and TRPML-1-mediated lysosomal exocytosis.

Journal: The Journal of cell biology
Published: January 03, 2024

A high-throughput approach to identify BRCA1-downregulating compounds to enhance PARP inhibitor sensitivity.

A high-throughput approach to identify BRCA1-downregulating compounds to enhance PARP inhibitor sensitivity.

Journal: iScience
Published: November 09, 2023

Correlates of Circulating Osteoprotegerin in Women with a Pathogenic or Likely Pathogenic Variant in the BRCA1 Gene.

Correlates of Circulating Osteoprotegerin in Women with a Pathogenic or Likely Pathogenic Variant in the BRCA1 Gene.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: May 20, 2023

Mitochondrion-targeted RNA therapies as a potential treatment strategy for mitochondrial diseases.

Mitochondrion-targeted RNA therapies as a potential treatment strategy for mitochondrial diseases.

Journal: Molecular therapy. Nucleic acids
Published: November 24, 2022
Showing 1-12 of 51

Last Updated: 09/26/2026